LMP1 Mediates Tumorigenesis Through Persistent Epigenetic Modifications and PGC1β Upregulation

Siliang Chen,Ping Zhang,Jia Feng,Rui Li,Junhui Chen,Wei V. Zheng,Hongyu Zhang,Paul Yao

DOI: https://doi.org/10.3892/or.2023.8490

2023-01-01

Oncology Reports

Abstract:Latent membrane protein 1 (LMP1), which is encoded by the Epstein-Barr virus (EBV), has been considered as an oncogene, although the detailed mechanism behind its function remains unclear. It has been previously reported that LMP1 promotes tumorigenesis by upregulation of peroxisome proliferator-activated receptor-gamma coactivator-1 beta (PGC1 beta). The present study aimed to investigate the potential mechanism for transient EBV/LMP1 exposure-mediated persistent PGC1 beta expression and subsequent tumorigenesis through modification of mitochondrial function. Luciferase reporter assay, chromatin immunoprecipitation and DNA mutation techniques were used to evaluate the PGC1 beta-mediated expression of dynamin-related protein 1 (DRP1). Tumorigenesis was evaluated by gene expression, oxidative stress, mitochondrial function and in vitro cellular proliferation assays. The potential effects of EBV, LMP1 and PGC1 beta on tumor growth were evaluated in an in vivo xenograft mouse model. The present in vitro experiments showed that LMP1 knockdown did not affect PGC1 beta expression or subsequent cell proliferation in EBV-positive tumor cells. PGC1 beta regulated DRP1 expression by coactivation of GA-binding protein alpha and nuclear respiratory factor 1 located on the DRP1 promoter, subsequently modulating mitochondrial fission. Transient exposure of either EBV or LMP1 in human hematopoietic stem cells caused persistent epigenetic changes and PGC1 beta upregulation after long-term cell culture even in the absence of EBV/LMP1, which decreased oxidative stress, and potentiated mitochondrial function and cell proliferation in vitro. Enhanced tumor growth and shortened survival were subsequently observed in vivo. It was concluded that PGC1 beta expression and subsequent cell proliferation were independent from LMP1 in EBV-positive tumor cells. PGC1 beta modulated mitochondria fission by regulation of DRP1 expression. Transient EBV/LMP1 exposure caused persistent PGC1 beta expression, triggering tumor growth in the absence of LMP1. The present study proposes a novel mechanism for transient EBV/LMP1 exposure-mediated tumorigenesis through persistent epigenetic changes and PGC1 beta upregulation, uncovering the reason why numerous forms of lymphoma exhibit upregulated PGC1 beta expression, but are devoid of EBV/LMP1.